Boston Scientific invests $1.5B in heart valve startup MiRus
MiRus, a startup focused on heart valve technology, has received a significant investment of $1.5 billion from Boston Scientific. As a result of this agreement, Boston Scientific now holds a 34% ownership in MiRus and has the opportunity to purchase its TAVR business for an extra $3 billion. This financial commitment underscores the increasing need for minimally invasive treatments for heart valves.
Key facts
- Boston Scientific invested $1.5 billion in MiRus
- Boston Scientific acquired a 34% stake in MiRus
- Boston Scientific has an option to buy MiRus's TAVR business for $3 billion
- MiRus is a heart valve startup
Entities
Institutions
- Boston Scientific
- MiRus
Sources
- Quartz —